United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Pharma Industry News Québec and Ottawa unite to fund Delpharm’s Boucherville upgrade for hospital drug security Find out how Delpharm’s C$220M investment is transforming its Boucherville plant into Canada’s sterile injectable powerhouse. byPallavi MadhirajuAugust 26, 2025